Applied Biosciences Corp
OTC:APPB
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Applied Biosciences Corp
OTC:APPB
|
1.4k USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Applied Biosciences Corp
Glance View
Applied BioSciences Corp. is a vertically integrated company, which focuses on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics or biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic area. The company is headquartered in New York City, New York. The company went IPO on 2015-11-04. The firm delivers cannabidiol (CBD) products as well as testing and analytics capabilities to its customers. The company sells consumer products, including health and wellness creams, tinctures, edibles, confections, clothing, apparel, and other various branded products. Its various brands include Remedi, Remedi Plus, HerbalPet, Champ Organics and Equine Care. Its products are focused on the medical, bioceutical and pet health industry. The firm source products from multiple production facilities in California, Colorado, Nevada and Florida. The firm's subsidiaries include Applied Products LLC, VitaCBD LLC, Trace Analytics, Inc., and SHL Management LLC, among others.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Applied Biosciences Corp’s Gross Margin has decreased from 86% to 61.4%. During this period, it reached a low of 6.7% on Jun 30, 2018 and a high of 86% on Mar 31, 2017.
